Tags: MDMAecstasyPTSD therapyjurisprudence2024-campaign
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Steve Hanley Clean Technica Scientist/Author. Professor at U. Penn. University of Pennsylvania | To Regulate Or Not Too Regulate — That Is The Question - 18 days ago | |
| 2 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
| 3 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | PBMs have evaded lawmakers’ reform attempts so far. Could 2025 turn the tide? - about 2 months ago | |
| 4 | Brooke Masters Financial Times US Financial Editor, FT. New York, USA | ||
| 5 | Stephen Gandel Financial Times Reinforcing priors since 1996. Manhattan, New York | ||
| 6 | Emily Olsen Healthcare Dive Reporter at Healthcare Dive. Loyola, Medill alum. Chicago, Illinois | ASTP finalizes pared down HTI-2 interoperability rule - 2 months ago | |
| 7 | Ethan Howland Utility Dive Senior Reporter, Utility Dive. Portland, Maine | Not just a ‘boondoggle’: State regulators, industrial companies push for cost effective transmission - 3 months ago Reregulation? How utilities and states are responding to PJM’s record capacity prices - 6 months ago States shouldn’t have to pay for transmission driven by other states’ policies: FERC’s Christie - 11 months ago | |
| 8 | Lars Mucklejohn City A.M. Banking reporter at CityAM. Contact via email. London | ||
| 9 | Charlie Conchie City A.M. London's business newspaper. London, England | ||
| 10 | Taylor Anderson Inman Talks about cities. | Commission chaos headed for Canada as watchdog probes rules - 5 months ago |